Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy

Supportive Care in Cancer

Volumn 23, Issue 9, 2015, Pages 2579-2587

  Junghaenel, Doerte U ^a   Cohen, Jules ^b   Schneider, Stefan ^a   Neerukonda, Anu R ^b   Broderick, Joan E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Breast cancer; Chemotherapy; Daily; Fatigue; Trajectory; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; AGE; ARTICLE; BODY WEIGHT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER FATIGUE; CANCER SIZE; DEPRESSION; DISEASE SEVERITY; EDUCATIONAL STATUS; EMOTION; EMOTIONAL DISORDER; EMOTIONAL STRESS; EMPLOYMENT; FEMALE; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILLNESS TRAJECTORY; INCOME; MAJOR CLINICAL STUDY; MARRIED PERSON; MASTECTOMY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PATIENT IDENTIFICATION; PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM; PHYSICAL ACTIVITY; PHYSICAL DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; SOCIAL INTERACTION; SOCIAL PROBLEM; ADJUVANT CHEMOTHERAPY; AGED; BREAST NEOPLASMS; FATIGUE; PATHOPHYSIOLOGY; PSYCHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEPRESSION; FATIGUE; FEMALE; HUMANS; MIDDLE AGED;

EID: 84938418671     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2616-x     Document Type: Article

References (45)

1. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C et al (2000) NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology 14:151–161
2. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360
3. Tiedtke C, de Rijk A, Dierckx de Casterle B, Christiaens MR, Donceel P (2010) Experiences and concerns about ‘returning to work’ for women breast cancer survivors: a literature review. Psychooncology 19:677–683
4. Gupta D, Lis CG, Grutsch JF (2007) The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manag 34:40–47
5. Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27–43
6. Tiesinga LJ, Dassen TW, Halfens RJ (1996) Fatigue: a summary of the definitions, dimensions, and indicators. Nurs Diagn 7:51–62
7. Magnusson K, Moller A, Ekman T, Wallgren A (1999) A qualitative study to explore the experience of fatigue in cancer patients. Eur J Cancer Care 8:224–232
8. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manag 18:233–242
9. Greene D, Nail LM, Fieler VK, Dudgeon D, Jones LS (1994) A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Pract 2:57–62
10. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23:6613–6622
11. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Nat Cancer Inst Monog 40-50.
12. Berger AM, Higginbotham P (2000) Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 27:1443–1448
13. de Jong N, Kester ADM, Schouten HC, Abu-Saad HH, Courtens AM (2006) Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs 29:467–477
14. Badr H, Basen-Engquist K, Carmack Taylor CL, De Moor C (2006) Mood states associated with transitory physical symptoms among breast and ovarian cancer survivors. J Behav Med 29:461–475
15. Jim HSL, Small B, Faul LA, Franzen J, Apte S, Jacobsen PB (2011) Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med 42:321–333
16. Passik SD, Kirsh KL, Donaghy K, Holtsclaw E, Theobald D, Cella D et al (2002) Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manag 24:481–493
17. Hilarius DL, Kloeg PH, van der Wall E, Komen M, Gundy CM, Aaronson NK (2011) Cancer-related fatigue: clinical practice versus practice guidelines. Support Care Cancer 19:531–538
18. Koornstra RH, Peters M, Donofrio S, van den Borne B, de Jong FA (2014) Management of fatigue in patients with cancer—a practical overview. Cancer Treat Rev 40:791–799
19. de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283–297
20. Jacobsen PB (2004) Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:93–97
21. Prue G, Rankin J, Allen J, Gracey J, Cramp F (2006) Cancer-related fatigue: a critical appraisal. Eur J Cancer 42:846–863
22. Watson T, Mock V (2004) Exercise as an intervention for cancer-related fatigue. Phys Ther 84:736–743
23. Christodoulou C, Schneider S, Junghaenel DU, Broderick JE, Stone AA (2014) Measuring daily fatigue using a brief scale adapted from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)). Qual Life Res 23:1245–1253
24. Christodoulou C, Junghaenel DU, DeWalt DA, Rothrock N, Stone AA (2008) Cognitive interviewing in the evaluation of fatigue items: results from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res 17:1239–1246
25. Riley WT, Rothrock N, Bruce B, Christodoulou C, Cook K, Hahn EA et al (2010) Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual Life Res 19:1311–1321
26. DeWalt DA, Rothrock N, Yount S, Stone AA (2007) Evaluation of item candidates: the PROMIS qualitative item review. Med Care 45:S12–S21
27. Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA et al (2007) Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 45:S22–S31
28. Lai JS, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R et al (2011) How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil 92:S20–S27
29. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S et al (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 63:1179–1194
30. Cook KF, Bamer AM, Amtmann D, Molton IR, Jensen MP (2012) Six patient-reported outcome measurement information system short form measures have negligible age- or diagnosis-related differential item functioning in individuals with disabilities. Arch Phys Med Rehabil 93:1289–1291
31. Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D (2010) Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol 63:1195–1204
32. Junghaenel DU, Christodoulou C, Lai JS, Stone AA (2011) Demographic correlates of fatigue in the US general population: results from the Patient-Reported Outcomes Measurement Information System (PROMISA) initiative. J Psychosom Res 71:117–123
33. Schneider S, Choi SW, Junghaenel DU, Schwartz JE, Stone AA (2013) Psychometric characteristics of daily diaries for the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): a preliminary investigation. Qual Life Res 22:1859–1869
34. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D (2009) Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 18:873–880
35. Revicki DA, Kawata AK, Harnam N, Chen WH, Hays RD, Cella D (2009) Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res 18:783–791
36. Jung T, Wickrama KAS (2008) An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Compass 2:302–317
37. Muthén B, Muthén LK (2000) Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res 24:882–891
38. Reinecke J, Seddig D (2011) Growth mixture models in longitudinal research. Asta-Adv Stat Anal 95:415–434
39. McLachlan G, Peel D (2000) Finite mixture models. Wiley, New York
40. Schafer JL, Graham JW (2002) Missing data: our view of the state of the art. Psychol Methods 7:147–177
41. Wang CP, Brown CH, Bandeen-Roche K (2005) Residual diagnostics for growth mixture models: Examining the impact of a preventive intervention on multiple trajectories of aggressive behavior. J Am Stat Assoc 100:1054–1076
42. Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New York
43. Muthén LK, Muthén BO (1998-2012) Mplus user’s guide, 7th ed. Los Angeles, CA: Muthén & Muthén
44. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753
45. Liu LQ, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR et al (2009) Pretreatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology 18:187–194